Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Medical Dosimetry
ISSN 0958-3947 · eISSN 1873-4022 · Elsevier Inc. · UNITED STATES · Quarterly · Founded 1987
Medical Dosimetry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.65; hybrid open access; APC about USD 2,500; median 104 days to acceptance (98 articles, last 24 months); community-reported acceptance: easy (Elsevier website: 23%); 76 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Medical Dosimetry is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Radiation Therapy and Dosimetry and Medical Imaging Techniques and Applications, together about 52.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the American Association of Medical DosimetristsMedical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief Cory NeillPublisher website
Editorial board by country: none in mainland China; most named United States 45, Malaysia 5, Thailand 4, Singapore 2, Canada 1 (58 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy31.8%
- Radiation Therapy and DosimetryMedicine11.8%
- Medical Imaging Techniques and ApplicationsMedicine8.4%
- Radiation Dose and ImagingMedicine6.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology3.9%
- Lung Cancer Diagnosis and TreatmentMedicine3.6%
- Head and Neck Cancer StudiesMedicine3%
- Advanced X-ray and CT ImagingEngineering2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.65LetPub ·
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher)
- 2.4Publisher website ·
- SJR 2026-06
- 0.5LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 34LetPub ·
- h-index
- 55OpenAlex ·
- i10-index
- 671OpenAlex ·
- 2-year mean citedness
- 0.94OpenAlex ·
- Self-citation rate
- 11.8%LetPub ·
- Share of gold OA articles
- 14.81%LetPub ·
Volume
- Articles per year
- 56LetPub ·
Articles by year OpenAlex count · 2,675 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 13 | 9 |
| 2025 | 76 | 21 | 57 |
| 2024 | 57 | 21 | 126 |
| 2023 | 69 | 21 | 274 |
| 2022 | 50 | 9 | 291 |
| 2021 | 69 | 13 | 375 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
104 daysMedian, submission to acceptance · P25–P75 67 days – 162 days
- Acceptance to online
- median 35 days (98 articles)
- Submission to online
- median 149 days
- Sample
- 98 articles with submission and acceptance dates (152 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- 23%LetPub ·
- Acceptance rate (publisher)
- 22%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 61 daysPublisher website ·
- Submission to acceptance
- 106 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,500 / EUR 2,340 / GBP 2,000 / JPY 310,080 | — | — | |
| Publisher website | USD 2,500 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- case studyc) A Case Study is a concise description of a technique, procedure, clinical implementation, or clinical patient-related complication of relevance to the practi…Length not stated
- didactic notee) A Didactic Note is a short explanation of technical or clinical concepts that are specifically relevant to the practice and understanding of medical dosimetr…Length not stated
- letter2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
- letter to the editor2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
- research article2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
- review2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
- review article2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
- technical note2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Lett…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Declaration of generative AI in scientific writing)
The below guidance only refers to the writing process, and not to the use of AI tools to analyze and draw insights from data as part of the research process.Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human ov…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Declaration of interests required from all authors. Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review; minimum two independent expert reviewers; Editor makes final decision. Model summary
This journal operates a single anonymized review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscripts. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about manuscripts which they have wri…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1987
- ISSN
- 0958-3947
- Electronic ISSN
- 1873-4022
- Society / sponsor
- American Association of Medical Dosimetrists
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Medical Dosimetry
What CAS zone is Medical Dosimetry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Medical Dosimetry is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Medical Dosimetry?
The latest impact factor listed by LetPub is 1.65; CiteScore 2.4, h-index 55.
How long does peer review take at Medical Dosimetry?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 67–162 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy (Elsevier website: 23%)”; the journal's website gives an acceptance rate of 22%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Medical Dosimetry based?
Of the 58 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (45), Malaysia (5) and Thailand (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Medical Dosimetry?
According to LetPub and DOAJ records, Medical Dosimetry is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Medical Dosimetry open access, and what is the APC?
Medical Dosimetry is a hybrid journal. For open-access publication: APC about USD 2,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .